ID   HDAC9_HUMAN             Reviewed;        1011 AA.
AC   Q9UKV0; A7E2F3; B7Z4I4; B7Z917; B7Z928; B7Z940; C9JS87; E7EX34;
AC   F8W9E0; O94845; O95028; Q2M2R6; Q86SL1; Q86US3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   18-OCT-2001, sequence version 2.
DT   07-JAN-2015, entry version 151.
DE   RecName: Full=Histone deacetylase 9;
DE            Short=HD9;
DE            EC=3.5.1.98;
DE   AltName: Full=Histone deacetylase 7B;
DE            Short=HD7;
DE            Short=HD7b;
DE   AltName: Full=Histone deacetylase-related protein;
DE   AltName: Full=MEF2-interacting transcription repressor MITR;
GN   Name=HDAC9; Synonyms=HDAC7, HDAC7B, HDRP, KIAA0744, MITR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), TISSUE SPECIFICITY,
RP   INTERACTION WITH MEF2, FUNCTION, AND ENZYME REGULATION.
RC   TISSUE=Brain;
RX   PubMed=11535832; DOI=10.1073/pnas.191375098;
RA   Zhou X., Marks P.A., Rifkind R.A., Richon V.M.;
RT   "Cloning and characterization of a histone deacetylase, HDAC9.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:10572-10577(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), TISSUE SPECIFICITY, AND
RP   CHROMOSOMAL TRANSLOCATION WITH TGFB2.
RC   TISSUE=Lens;
RX   PubMed=12706107; DOI=10.1016/S0888-7543(03)00046-6;
RA   David D., Cardoso J., Marques B., Marques R., Silva E.D., Santos H.,
RA   Boavida M.G.;
RT   "Molecular characterization of a familial translocation implicates
RT   disruption of HDAC9 and possible position effect on TGFbeta2 in the
RT   pathogenesis of Peters' anomaly.";
RL   Genomics 81:489-503(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 7), TISSUE SPECIFICITY,
RP   ALTERNATIVE SPLICING (ISOFORMS 3; 6 AND 7), INTERACTION WITH ETV6;
RP   NCOR1 AND BCL6, FUNCTION, SUBCELLULAR LOCATION, AND SUMOYLATION.
RC   TISSUE=Brain;
RX   PubMed=12590135; DOI=10.1074/jbc.M212935200;
RA   Petrie K., Guidez F., Howell L., Healy L., Waxman S., Greaves M.,
RA   Zelent A.;
RT   "The histone deacetylase 9 gene encodes multiple protein isoforms.";
RL   J. Biol. Chem. 278:16059-16072(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=9872452; DOI=10.1093/dnares/5.5.277;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XI.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 5:277-286(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 8; 9; 10 AND 11).
RC   TISSUE=Brain, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 2-1011 (ISOFORM 6).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 99-650 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=10523670;
RA   Wang A.H., Bertos N.R., Vezmar M., Pelletier N., Crosato M.,
RA   Heng H.H., Th'ng J., Han J., Yang X.-J.;
RT   "HDAC4, a human histone deacetylase related to yeast HDA1, is a
RT   transcriptional corepressor.";
RL   Mol. Cell. Biol. 19:7816-7827(1999).
RN   [10]
RP   IDENTIFICATION (ISOFORM 3), INTERACTION WITH HDAC1, AND FUNCTION.
RX   PubMed=10487760; DOI=10.1093/emboj/18.18.5085;
RA   Sparrow D.B., Miska E.A., Langley E., Reynaud-Deonauth S., Kotecha S.,
RA   Towers N., Spohr G., Kouzarides T., Mohun T.J.;
RT   "MEF-2 function is modified by a novel co-repressor, MITR.";
RL   EMBO J. 18:5085-5098(1999).
RN   [11]
RP   IDENTIFICATION (ISOFORM 3), TISSUE SPECIFICITY, INTERACTION WITH HDAC1
RP   AND HDAC3, AND FUNCTION.
RX   PubMed=10655483; DOI=10.1073/pnas.97.3.1056;
RA   Zhou X., Richon V.M., Rifkind R.A., Marks P.A.;
RT   "Identification of a transcriptional repressor related to the
RT   noncatalytic domain of histone deacetylases 4 and 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:1056-1061(2000).
RN   [12]
RP   INTERACTION WITH MEF2.
RX   PubMed=10487761; DOI=10.1093/emboj/18.18.5099;
RA   Miska E.A., Karlsson C., Langley E., Nielsen S.J., Pines J.,
RA   Kouzarides T.;
RT   "HDAC4 deacetylase associates with and represses the MEF2
RT   transcription factor.";
RL   EMBO J. 18:5099-5107(1999).
RN   [13]
RP   SUMOYLATION.
RX   PubMed=12032081; DOI=10.1093/emboj/21.11.2682;
RA   Kirsh O., Seeler J.-S., Pichler A., Gast A., Mueller S., Miska E.,
RA   Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A.;
RT   "The SUMO E3 ligase RanBP2 promotes modification of the HDAC4
RT   deacetylase.";
RL   EMBO J. 21:2682-2691(2002).
RN   [14]
RP   FUNCTION.
RX   PubMed=16611996; DOI=10.1128/MCB.26.9.3550-3564.2006;
RA   Morrison B.E., Majdzadeh N., Zhang X., Lyles A., Bassel-Duby R.,
RA   Olson E.N., D'Mello S.R.;
RT   "Neuroprotection by histone deacetylase-related protein.";
RL   Mol. Cell. Biol. 26:3550-3564(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION.
RX   PubMed=20188095; DOI=10.1016/j.febslet.2010.02.057;
RA   Harrison B.C., Huynh K., Lundgaard G.L., Helmke S.M., Perryman M.B.,
RA   McKinsey T.A.;
RT   "Protein kinase C-related kinase targets nuclear localization signals
RT   in a subset of class IIa histone deacetylases.";
RL   FEBS Lett. 584:1103-1110(2010).
RN   [17]
RP   VARIANT THR-921.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P.,
RA   Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A.,
RA   Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C.,
RA   Jia M., Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A.,
RA   Mudie L., Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S.,
RA   Kahnoski R.J., Anema J., Tuveson D.A., Perez-Mancera P.A.,
RA   Mustonen V., Fischer A., Adams D.J., Rust A., Chan-On W., Subimerb C.,
RA   Dykema K., Furge K., Campbell P.J., Teh B.T., Stratton M.R.,
RA   Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex
RT   gene PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
CC   -!- FUNCTION: Responsible for the deacetylation of lysine residues on
CC       the N-terminal part of the core histones (H2A, H2B, H3 and H4).
CC       Histone deacetylation gives a tag for epigenetic repression and
CC       plays an important role in transcriptional regulation, cell cycle
CC       progression and developmental events. Represses MEF2-dependent
CC       transcription.
CC   -!- FUNCTION: Isoform 3 lacks active site residues and therefore is
CC       catalytically inactive. Represses MEF2-dependent transcription by
CC       recruiting HDAC1 and/or HDAC3. Seems to inhibit skeletal
CC       myogenesis and to be involved in heart development. Protects
CC       neurons from apoptosis, both by inhibiting JUN phosphorylation by
CC       MAPK10 and by repressing JUN transcription via HDAC1 recruitment
CC       to JUN promoter.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of an N(6)-acetyl-lysine residue of
CC       a histone to yield a deacetylated histone.
CC   -!- ENZYME REGULATION: Inhibited by Trichostatin A (TSA) and
CC       suberoylanilide hydroxamic acid. {ECO:0000269|PubMed:11535832}.
CC   -!- SUBUNIT: Homodimer. Interacts with CTBP1. The phosphorylated form
CC       interacts with 14-3-3 (By similarity). Interacts with HDAC1 and
CC       HDAC3, and probably with HDAC4 and HDAC5. Interacts with MEF2,
CC       MAPK10, ETV6, NCOR1 and BCL6. {ECO:0000250,
CC       ECO:0000269|PubMed:10487760, ECO:0000269|PubMed:10487761,
CC       ECO:0000269|PubMed:10655483, ECO:0000269|PubMed:11535832,
CC       ECO:0000269|PubMed:12590135}.
CC   -!- INTERACTION:
CC       P41182:BCL6; NbExp=2; IntAct=EBI-765444, EBI-765407;
CC       P41212:ETV6; NbExp=3; IntAct=EBI-765476, EBI-1372759;
CC       Q60974:Ncor1 (xeno); NbExp=3; IntAct=EBI-1372717, EBI-349004;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q9UKV0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKV0-2; Sequence=VSP_002082;
CC       Name=3; Synonyms=HDRP, MITR;
CC         IsoId=Q9UKV0-3; Sequence=VSP_002083, VSP_002084;
CC         Note=Major form in most tissues. Inactive due to lack of active
CC         site residues.;
CC       Name=4; Synonyms=HDAC9a;
CC         IsoId=Q9UKV0-4; Sequence=VSP_002085, VSP_002086;
CC       Name=5; Synonyms=HDAC9b, HDAC9fl;
CC         IsoId=Q9UKV0-5; Sequence=VSP_023768;
CC         Note=Contains a phosphotyrosine at position 1007. {ECO:0000305};
CC       Name=6;
CC         IsoId=Q9UKV0-6; Sequence=VSP_023766, VSP_023767, VSP_023768;
CC         Note=Ref.8 (AAI11736) sequence differs from that shown due to a
CC         frameshift in position 1021. Contains a phosphotyrosine at
CC         position 966 (Probable). Excluded from the nucleus. Does not
CC         interact with ETV6.. {ECO:0000305};
CC       Name=7;
CC         IsoId=Q9UKV0-7; Sequence=VSP_023766, VSP_023768;
CC       Name=8;
CC         IsoId=Q9UKV0-8; Sequence=VSP_043428, VSP_023767, VSP_002083,
CC                                  VSP_002084;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=Q9UKV0-9; Sequence=VSP_023767, VSP_002083, VSP_002084;
CC       Name=10;
CC         IsoId=Q9UKV0-10; Sequence=VSP_046827, VSP_023766, VSP_002083,
CC                                   VSP_002084;
CC       Name=11;
CC         IsoId=Q9UKV0-11; Sequence=VSP_046827, VSP_046828, VSP_023767,
CC                                   VSP_002083, VSP_002084;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in
CC       brain, heart, muscle and testis. Isoform 3 is present in human
CC       bladder carcinoma cells (at protein level).
CC       {ECO:0000269|PubMed:10655483, ECO:0000269|PubMed:11535832,
CC       ECO:0000269|PubMed:12590135, ECO:0000269|PubMed:12706107}.
CC   -!- PTM: Phosphorylated on Ser-220 and Ser-450; which promotes 14-3-3-
CC       binding, impairs interaction with MEF2, and antagonizes
CC       antimyogenic activity. Phosphorylated on Ser-240; which impairs
CC       nuclear accumulation (By similarity). Isoform 7 is phosphorylated
CC       on Tyr-1010. Phosphorylated by the PKC kinases PKN1 and PKN2,
CC       impairing nuclear import. {ECO:0000250,
CC       ECO:0000269|PubMed:19690332, ECO:0000269|PubMed:20188095}.
CC   -!- PTM: Sumoylated. {ECO:0000269|PubMed:12032081,
CC       ECO:0000269|PubMed:12590135}.
CC   -!- DISEASE: Note=A chromosomal aberration involving HDAC9 is found in
CC       a family with Peters anomaly. Translocation t(1;7)(q41;p21) with
CC       TGFB2 resulting in lack of HDAC9 protein.
CC   -!- SIMILARITY: Belongs to the histone deacetylase family. HD type 2
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA34464.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY032737; AAK66821.1; -; mRNA.
DR   EMBL; AY032738; AAK66822.1; -; mRNA.
DR   EMBL; AJ459808; CAD30851.1; -; mRNA.
DR   EMBL; AY197371; AAO27363.1; -; mRNA.
DR   EMBL; AB018287; BAA34464.2; ALT_INIT; mRNA.
DR   EMBL; AK297404; BAH12570.1; -; mRNA.
DR   EMBL; AK304298; BAH14153.1; -; mRNA.
DR   EMBL; AK304343; BAH14164.1; -; mRNA.
DR   EMBL; AK304410; BAH14176.1; -; mRNA.
DR   EMBL; AC002088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002124; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC002433; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004744; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC004994; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005249; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC010082; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC074193; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091697; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471073; EAW93702.1; -; Genomic_DNA.
DR   EMBL; CH471073; EAW93703.1; -; Genomic_DNA.
DR   EMBL; BC111735; AAI11736.1; ALT_FRAME; mRNA.
DR   EMBL; BC150328; AAI50329.1; -; mRNA.
DR   EMBL; BC152405; AAI52406.1; -; mRNA.
DR   EMBL; AF124924; AAF04254.1; -; mRNA.
DR   CCDS; CCDS47553.1; -. [Q9UKV0-7]
DR   CCDS; CCDS47554.1; -. [Q9UKV0-5]
DR   CCDS; CCDS47555.1; -. [Q9UKV0-1]
DR   CCDS; CCDS47557.1; -. [Q9UKV0-3]
DR   CCDS; CCDS56465.1; -. [Q9UKV0-8]
DR   CCDS; CCDS56466.1; -. [Q9UKV0-9]
DR   CCDS; CCDS56467.1; -. [Q9UKV0-10]
DR   CCDS; CCDS56468.1; -. [Q9UKV0-11]
DR   RefSeq; NP_001191073.1; NM_001204144.1. [Q9UKV0-8]
DR   RefSeq; NP_001191074.1; NM_001204145.1. [Q9UKV0-9]
DR   RefSeq; NP_001191075.1; NM_001204146.1.
DR   RefSeq; NP_001191076.1; NM_001204147.1. [Q9UKV0-11]
DR   RefSeq; NP_001191077.1; NM_001204148.1. [Q9UKV0-10]
DR   RefSeq; NP_055522.1; NM_014707.1. [Q9UKV0-3]
DR   RefSeq; NP_478056.1; NM_058176.2. [Q9UKV0-1]
DR   RefSeq; NP_848510.1; NM_178423.1. [Q9UKV0-5]
DR   RefSeq; NP_848512.1; NM_178425.2. [Q9UKV0-7]
DR   UniGene; Hs.196054; -.
DR   ProteinModelPortal; Q9UKV0; -.
DR   SMR; Q9UKV0; 629-1005.
DR   BioGrid; 115083; 99.
DR   DIP; DIP-39904N; -.
DR   IntAct; Q9UKV0; 29.
DR   MINT; MINT-205121; -.
DR   STRING; 9606.ENSP00000408617; -.
DR   BindingDB; Q9UKV0; -.
DR   ChEMBL; CHEMBL4145; -.
DR   DrugBank; DB00313; Valproic Acid.
DR   GuidetoPHARMACOLOGY; 2620; -.
DR   PhosphoSite; Q9UKV0; -.
DR   DMDM; 19865267; -.
DR   MaxQB; Q9UKV0; -.
DR   PaxDb; Q9UKV0; -.
DR   PRIDE; Q9UKV0; -.
DR   DNASU; 9734; -.
DR   Ensembl; ENST00000401921; ENSP00000383912; ENSG00000048052. [Q9UKV0-6]
DR   Ensembl; ENST00000405010; ENSP00000384382; ENSG00000048052. [Q9UKV0-3]
DR   Ensembl; ENST00000406451; ENSP00000384657; ENSG00000048052. [Q9UKV0-5]
DR   Ensembl; ENST00000417496; ENSP00000401669; ENSG00000048052. [Q9UKV0-8]
DR   Ensembl; ENST00000428307; ENSP00000395655; ENSG00000048052. [Q9UKV0-9]
DR   Ensembl; ENST00000432645; ENSP00000410337; ENSG00000048052. [Q9UKV0-1]
DR   Ensembl; ENST00000441542; ENSP00000408617; ENSG00000048052. [Q9UKV0-7]
DR   Ensembl; ENST00000456174; ENSP00000388568; ENSG00000048052. [Q9UKV0-10]
DR   Ensembl; ENST00000524023; ENSP00000430036; ENSG00000048052. [Q9UKV0-11]
DR   GeneID; 9734; -.
DR   KEGG; hsa:9734; -.
DR   UCSC; uc003sua.1; human. [Q9UKV0-6]
DR   UCSC; uc003sud.2; human. [Q9UKV0-3]
DR   UCSC; uc003sue.3; human. [Q9UKV0-5]
DR   UCSC; uc003suf.2; human. [Q9UKV0-7]
DR   UCSC; uc003suh.3; human. [Q9UKV0-1]
DR   UCSC; uc011jya.2; human. [Q9UKV0-8]
DR   UCSC; uc011jyd.2; human. [Q9UKV0-4]
DR   UCSC; uc011jye.2; human.
DR   CTD; 9734; -.
DR   GeneCards; GC07P018179; -.
DR   HGNC; HGNC:14065; HDAC9.
DR   HPA; HPA028926; -.
DR   MIM; 606543; gene.
DR   neXtProt; NX_Q9UKV0; -.
DR   Orphanet; 708; Peters anomaly.
DR   PharmGKB; PA38377; -.
DR   eggNOG; COG0123; -.
DR   GeneTree; ENSGT00530000062809; -.
DR   HOGENOM; HOG000232065; -.
DR   HOVERGEN; HBG057100; -.
DR   InParanoid; Q9UKV0; -.
DR   KO; K11409; -.
DR   OMA; TPPLGGY; -.
DR   OrthoDB; EOG7RFTH5; -.
DR   PhylomeDB; Q9UKV0; -.
DR   TreeFam; TF106174; -.
DR   BRENDA; 3.5.1.98; 2681.
DR   Reactome; REACT_118780; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; REACT_160243; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; REACT_160254; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   ChiTaRS; HDAC9; human.
DR   GeneWiki; HDAC9; -.
DR   GenomeRNAi; 9734; -.
DR   NextBio; 36620; -.
DR   PRO; PR:Q9UKV0; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; Q9UKV0; -.
DR   CleanEx; HS_HDAC7; -.
DR   CleanEx; HS_HDAC9; -.
DR   ExpressionAtlas; Q9UKV0; baseline and differential.
DR   Genevestigator; Q9UKV0; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0000118; C:histone deacetylase complex; TAS:UniProtKB.
DR   GO; GO:0035097; C:histone methyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005667; C:transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0004407; F:histone deacetylase activity; IDA:BHF-UCL.
DR   GO; GO:0042826; F:histone deacetylase binding; IDA:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032041; F:NAD-dependent histone deacetylase activity (H3-K14 specific); IEA:UniProtKB-EC.
DR   GO; GO:0097372; F:NAD-dependent histone deacetylase activity (H3-K18 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046969; F:NAD-dependent histone deacetylase activity (H3-K9 specific); IEA:UniProtKB-EC.
DR   GO; GO:0046970; F:NAD-dependent histone deacetylase activity (H4-K16 specific); IEA:UniProtKB-EC.
DR   GO; GO:0033558; F:protein deacetylase activity; IDA:BHF-UCL.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:UniProtKB.
DR   GO; GO:0070491; F:repressing transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:BHF-UCL.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0042113; P:B cell activation; TAS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; TAS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IDA:BHF-UCL.
DR   GO; GO:0007507; P:heart development; ISS:BHF-UCL.
DR   GO; GO:0016575; P:histone deacetylation; IDA:BHF-UCL.
DR   GO; GO:0070932; P:histone H3 deacetylation; IDA:BHF-UCL.
DR   GO; GO:0070933; P:histone H4 deacetylation; IDA:BHF-UCL.
DR   GO; GO:0006954; P:inflammatory response; TAS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0034983; P:peptidyl-lysine deacetylation; IDA:BHF-UCL.
DR   GO; GO:0090050; P:positive regulation of cell migration involved in sprouting angiogenesis; IMP:BHF-UCL.
DR   GO; GO:0048742; P:regulation of skeletal muscle fiber development; ISS:UniProtKB.
DR   GO; GO:0051153; P:regulation of striated muscle cell differentiation; ISS:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.800.20; -; 1.
DR   InterPro; IPR000286; His_deacetylse.
DR   InterPro; IPR023801; His_deacetylse_dom.
DR   InterPro; IPR024643; Hist_deacetylase_Gln_rich_N.
DR   InterPro; IPR017320; Histone_deAcase_II_euk.
DR   PANTHER; PTHR10625; PTHR10625; 1.
DR   Pfam; PF12203; HDAC4_Gln; 1.
DR   Pfam; PF00850; Hist_deacetyl; 1.
DR   PIRSF; PIRSF037911; HDAC_II_euk; 1.
DR   PRINTS; PR01270; HDASUPER.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromatin regulator; Chromosomal rearrangement;
KW   Complete proteome; Hydrolase; Metal-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc.
FT   CHAIN         1   1011       Histone deacetylase 9.
FT                                /FTId=PRO_0000114710.
FT   REGION       23     27       Interaction with CTBP1. {ECO:0000250}.
FT   REGION      136    154       Interaction with MEF2. {ECO:0000250}.
FT   REGION      175    343       Interaction with MAPK10. {ECO:0000250}.
FT   REGION      218    261       Interaction with ETV6.
FT   REGION      631    978       Histone deacetylase.
FT   ACT_SITE    783    783       {ECO:0000250}.
FT   METAL       646    646       Zinc. {ECO:0000250}.
FT   METAL       648    648       Zinc. {ECO:0000250}.
FT   METAL       654    654       Zinc. {ECO:0000250}.
FT   METAL       731    731       Zinc. {ECO:0000250}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   MOD_RES     220    220       Phosphoserine. {ECO:0000250}.
FT   MOD_RES     240    240       Phosphoserine. {ECO:0000250}.
FT   MOD_RES     451    451       Phosphoserine. {ECO:0000250}.
FT   VAR_SEQ       1     31       Missing (in isoform 10 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046827.
FT   VAR_SEQ       1      1       M -> MMSSPAQPDLMWNLVPWVLFCGCCRIFPDGVAGREQ
FT                                LLAQQRM (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043428.
FT   VAR_SEQ      88     88       K -> KLQQ (in isoform 6, isoform 7 and
FT                                isoform 10).
FT                                {ECO:0000303|PubMed:12590135,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023766.
FT   VAR_SEQ     177    178       Missing (in isoform 11).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_046828.
FT   VAR_SEQ     218    261       Missing (in isoform 6, isoform 8, isoform
FT                                9 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023767.
FT   VAR_SEQ     487    574       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10523670}.
FT                                /FTId=VSP_002082.
FT   VAR_SEQ     575    590       PFLEPTHTRALSVRQA -> VIGKDLAPGFVIKVII (in
FT                                isoform 3, isoform 8, isoform 9, isoform
FT                                10 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9872452}.
FT                                /FTId=VSP_002083.
FT   VAR_SEQ     591   1011       Missing (in isoform 3, isoform 8, isoform
FT                                9, isoform 10 and isoform 11).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:9872452}.
FT                                /FTId=VSP_002084.
FT   VAR_SEQ     861    879       GTGLGEGYNINIAWTGGLD -> RFISLEPHFYLYLSGNCI
FT                                A (in isoform 4).
FT                                {ECO:0000303|PubMed:11535832}.
FT                                /FTId=VSP_002085.
FT   VAR_SEQ     880   1011       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:11535832}.
FT                                /FTId=VSP_002086.
FT   VAR_SEQ    1006   1011       MSLKFS -> KYWKSVRMVAVPRGCALAGAQLQEETETVSA
FT                                LASLTVDVEQPFAQEDSRTAGEPMEEEPAL (in
FT                                isoform 5, isoform 6 and isoform 7).
FT                                {ECO:0000303|PubMed:12590135,
FT                                ECO:0000303|PubMed:12706107,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023768.
FT   VARIANT     921    921       P -> T (found in a renal cell carcinoma
FT                                sample; somatic mutation).
FT                                {ECO:0000269|PubMed:21248752}.
FT                                /FTId=VAR_064719.
FT   CONFLICT     16     16       V -> A (in Ref. 5; BAH12570).
FT                                {ECO:0000305}.
FT   CONFLICT     99     99       L -> I (in Ref. 9; AAF04254).
FT                                {ECO:0000305}.
FT   CONFLICT    153    153       S -> I (in Ref. 5; BAH14164).
FT                                {ECO:0000305}.
FT   CONFLICT    315    315       S -> F (in Ref. 5; BAH14176).
FT                                {ECO:0000305}.
FT   CONFLICT    332    332       L -> M (in Ref. 5; BAH14164).
FT                                {ECO:0000305}.
FT   CONFLICT    416    416       V -> F (in Ref. 5; BAH14164).
FT                                {ECO:0000305}.
FT   CONFLICT    437    437       T -> P (in Ref. 9; AAF04254).
FT                                {ECO:0000305}.
FT   CONFLICT    644    647       HQCV -> KPNS (in Ref. 9; AAF04254).
FT                                {ECO:0000305}.
FT   CONFLICT    746    746       H -> R (in Ref. 3; AAO27363).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1011 AA;  111297 MW;  43ED2785E73CD924 CRC64;
     MHSMISSVDV KSEVPVGLEP ISPLDLRTDL RMMMPVVDPV VREKQLQQEL LLIQQQQQIQ
     KQLLIAEFQK QHENLTRQHQ AQLQEHIKEL LAIKQQQELL EKEQKLEQQR QEQEVERHRR
     EQQLPPLRGK DRGRERAVAS TEVKQKLQEF LLSKSATKDT PTNGKNHSVS RHPKLWYTAA
     HHTSLDQSSP PLSGTSPSYK YTLPGAQDAK DDFPLRKTAS EPNLKVRSRL KQKVAERRSS
     PLLRRKDGNV VTSFKKRMFE VTESSVSSSS PGSGPSSPNN GPTGSVTENE TSVLPPTPHA
     EQMVSQQRIL IHEDSMNLLS LYTSPSLPNI TLGLPAVPSQ LNASNSLKEK QKCETQTLRQ
     GVPLPGQYGG SIPASSSHPH VTLEGKPPNS SHQALLQHLL LKEQMRQQKL LVAGGVPLHP
     QSPLATKERI SPGIRGTHKL PRHRPLNRTQ SAPLPQSTLA QLVIQQQHQQ FLEKQKQYQQ
     QIHMNKLLSK SIEQLKQPGS HLEEAEEELQ GDQAMQEDRA PSSGNSTRSD SSACVDDTLG
     QVGAVKVKEE PVDSDEDAQI QEMESGEQAA FMQQPFLEPT HTRALSVRQA PLAAVGMDGL
     EKHRLVSRTH SSPAASVLPH PAMDRPLQPG SATGIAYDPL MLKHQCVCGN STTHPEHAGR
     IQSIWSRLQE TGLLNKCERI QGRKASLEEI QLVHSEHHSL LYGTNPLDGQ KLDPRILLGD
     DSQKFFSSLP CGGLGVDSDT IWNELHSSGA ARMAVGCVIE LASKVASGEL KNGFAVVRPP
     GHHAEESTAM GFCFFNSVAI TAKYLRDQLN ISKILIVDLD VHHGNGTQQA FYADPSILYI
     SLHRYDEGNF FPGSGAPNEV GTGLGEGYNI NIAWTGGLDP PMGDVEYLEA FRTIVKPVAK
     EFDPDMVLVS AGFDALEGHT PPLGGYKVTA KCFGHLTKQL MTLADGRVVL ALEGGHDLTA
     ICDASEACVN ALLGNELEPL AEDILHQSPN MNAVISLQKI IEIQSMSLKF S
//
